1 Min Read
June 9 (Reuters) - Proteomics International Laboratories Ltd
* Seeks trading halt pending an announcement of results from promarkerd clinical validation study Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.